Since it is well established that PDL-1 overexpression is significant in glioma samples, emerged data by using different glioma cell lines, murine and human samples, support the negative survival signal of PD-1/PD-L1 pathway may represent immune suppression mechanism employed by malignant brain tumors. Here, CD274 is linked to glioma.